Biogen (BIIB) News Today $119.26 +4.09 (+3.55%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Eisai, Biogen announce update on regulatory review of MAA for lecanemabApril 14 at 8:50 PM | markets.businessinsider.comBiogen (BIIB) Receives a Hold from JefferiesApril 14 at 8:50 PM | markets.businessinsider.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Neuberger Berman Group LLCNeuberger Berman Group LLC lowered its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 89.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,442 shares of the biotechnology company's stock after selling 28,657 shares during the period. NeubeApril 14 at 5:58 AM | marketbeat.comLSV Asset Management Buys 192,948 Shares of Biogen Inc. (NASDAQ:BIIB)LSV Asset Management grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 464.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 234,448 shares of the biotechnology company's stock after purchasing anApril 14 at 5:50 AM | marketbeat.comFIL Ltd Has $16.01 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)FIL Ltd reduced its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 46.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 104,717 shares of the biotechnology companyApril 14 at 4:58 AM | marketbeat.comCantor Fitzgerald Forecasts Lower Earnings for BiogenBiogen Inc. (NASDAQ:BIIB - Free Report) - Investment analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for shares of Biogen in a research report issued on Wednesday, April 9th. Cantor Fitzgerald analyst E. Schmidt now forecasts that the biotechnology company will pApril 13 at 8:02 AM | marketbeat.comFirst Foundation Advisors Boosts Stock Holdings in Biogen Inc. (NASDAQ:BIIB)First Foundation Advisors lifted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 32.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,352 shares of the biotechnology company's stockApril 13 at 7:05 AM | marketbeat.comPhoenix Financial Ltd. Acquires New Position in Biogen Inc. (NASDAQ:BIIB)Phoenix Financial Ltd. bought a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 3,608 shares of the biotechnology company's stock, valued at approxApril 13 at 6:27 AM | marketbeat.comAPG Asset Management N.V. Purchases 81,811 Shares of Biogen Inc. (NASDAQ:BIIB)APG Asset Management N.V. increased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 346.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 105,446 shares of the biotechnology company's stock after acquApril 13 at 5:56 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Bank of Montreal CanBank of Montreal Can reduced its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 211,336 shares of the biotechnology company's stock after selling 8,5April 13 at 5:26 AM | marketbeat.comLPL Financial LLC Has $4 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)LPL Financial LLC lowered its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 43.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 26,138 shares of the biotechnology company's stock after selling 20,253 shares during the period. LPL FiApril 13 at 3:39 AM | marketbeat.comFY2025 EPS Estimates for Biogen Cut by Cantor FitzgeraldApril 13 at 1:45 AM | americanbankingnews.comAPG Asset Management US Inc. Buys New Position in Biogen Inc. (NASDAQ:BIIB)APG Asset Management US Inc. purchased a new stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,010 shares of the biotechnology company's stock,April 12 at 6:54 AM | marketbeat.comMartingale Asset Management L P Has $5.34 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Martingale Asset Management L P cut its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 37.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 34,922 shares of the biotechnology company's sApril 12 at 6:47 AM | marketbeat.comLegal & General Group Plc Lowers Stock Position in Biogen Inc. (NASDAQ:BIIB)Legal & General Group Plc decreased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 18.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,230,007 shares of the biotechnology company's stock afteApril 12 at 6:01 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Purchased by Invesco Ltd.Invesco Ltd. boosted its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 30.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,128,807 shares of the biotechnology company's stock after purchasing an additional 499,074April 12 at 5:53 AM | marketbeat.comRussell Investments Group Ltd. Decreases Position in Biogen Inc. (NASDAQ:BIIB)Russell Investments Group Ltd. lowered its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 7.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 121,763 shares of the biotechnology company's stock after selApril 12 at 5:21 AM | marketbeat.comMorgan Stanley Lowers Biogen (NASDAQ:BIIB) Price Target to $152.00Morgan Stanley decreased their target price on Biogen from $157.00 to $152.00 and set an "equal weight" rating on the stock in a research note on Wednesday.April 11, 2025 | marketbeat.comAnalysts Set Biogen Inc. (NASDAQ:BIIB) PT at $213.33April 11, 2025 | americanbankingnews.comMorgan Stanley Cuts Biogen (NASDAQ:BIIB) Price Target to $152.00April 11, 2025 | americanbankingnews.comBiogen price target lowered to $165 from $168 at GuggenheimApril 10, 2025 | markets.businessinsider.comGuggenheim Adjusts Target for Biogen (BIIB) Ahead of Q1 Earnings | BIIB Stock NewsApril 10, 2025 | gurufocus.comRenaissance Technologies LLC Purchases 239,500 Shares of Biogen Inc. (NASDAQ:BIIB)Renaissance Technologies LLC raised its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 25.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,192,206 shares of the biotechnoApril 10, 2025 | marketbeat.comAviva PLC Raises Stake in Biogen Inc. (NASDAQ:BIIB)Aviva PLC lifted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 373.4% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 87,731 shares of the biotechnology company's stock after buying an additional 69,199 shares during the period. AvApril 10, 2025 | marketbeat.comResona Asset Management Co. Ltd. Invests $6.81 Million in Biogen Inc. (NASDAQ:BIIB)Resona Asset Management Co. Ltd. bought a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 44,608 shares of the biotechnology company's stock, valued at appApril 10, 2025 | marketbeat.comBiogen price target lowered to $152 from $157 at Morgan StanleyApril 9, 2025 | markets.businessinsider.comMorgan Stanley Reaffirms Their Hold Rating on Biogen (BIIB)April 9, 2025 | markets.businessinsider.comADAR1 Capital Management LLC Sells 26,580 Shares of Biogen Inc. (NASDAQ:BIIB)ADAR1 Capital Management LLC cut its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 89.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,045 shares of the biotechnology company's stock after selling 26,5April 9, 2025 | marketbeat.comSage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price TagApril 9, 2025 | seekingalpha.comBiogen Inc. (NASDAQ:BIIB) Receives Average Rating of "Hold" from AnalystsShares of Biogen Inc. (NASDAQ:BIIB - Get Free Report) have received an average rating of "Hold" from the thirty-one analysts that are covering the firm, Marketbeat Ratings reports. Eighteen research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendApril 9, 2025 | marketbeat.comIlmarinen Mutual Pension Insurance Co Boosts Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Ilmarinen Mutual Pension Insurance Co raised its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 33.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,000 shares of the biotechnology company's stApril 8, 2025 | marketbeat.comTrexquant Investment LP Reduces Stake in Biogen Inc. (NASDAQ:BIIB)Trexquant Investment LP cut its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 75.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,337 shares of the biotechnology company's stock after selling 73,259 shares during the period.April 8, 2025 | marketbeat.comSpotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4April 7, 2025 | msn.comRhenman & Partners Asset Management AB Acquires 56,600 Shares of Biogen Inc. (NASDAQ:BIIB)Rhenman & Partners Asset Management AB raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 84.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 123,700 shares of the biotechnology company's stock after purcApril 7, 2025 | marketbeat.comIntegrated Quantitative Investments LLC Makes New $407,000 Investment in Biogen Inc. (NASDAQ:BIIB)Integrated Quantitative Investments LLC purchased a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,660 shares of the biotechnology company's sApril 7, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Has $112 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Massachusetts Financial Services Co. MA raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 732,376 shares of the biotechnologyApril 7, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Sets New 12-Month Low - Here's WhyBiogen (NASDAQ:BIIB) Reaches New 12-Month Low - What's Next?April 6, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Rating Lowered to "Hold" at ArgusArgus cut shares of Biogen from a "buy" rating to a "hold" rating in a research note on Friday.April 6, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Stake Raised by Geode Capital Management LLCGeode Capital Management LLC raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,695,476 shares of the bApril 6, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Stock Position Cut by Schroder Investment Management GroupSchroder Investment Management Group trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 33.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,615 shares of the biotechnology compaApril 6, 2025 | marketbeat.comBiogen downgraded to Hold from Buy at ArgusApril 5, 2025 | markets.businessinsider.comBiogen cut to Hold at Argus on expected earnings declineApril 5, 2025 | markets.businessinsider.comBiogen Inc. (BIIB) Stock ForecastsApril 5, 2025 | finance.yahoo.comArgus Research Downgrades Biogen (BIIB)April 5, 2025 | msn.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by National Bank of Canada FINational Bank of Canada FI lessened its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 7.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 177,889 shares of the biotechnology company's stock after seApril 5, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Acquired by Franklin Resources Inc.Franklin Resources Inc. boosted its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 5.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 394,391 shares of the biotechnology company's stock after acquiriApril 5, 2025 | marketbeat.comClearbridge Investments LLC Has $242,000 Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Clearbridge Investments LLC reduced its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 99.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,584 shares of the biotechnology company's stock after selling 600,402 shares during the quarter.April 5, 2025 | marketbeat.comArgus Downgrades Biogen (NASDAQ:BIIB) to HoldApril 5, 2025 | americanbankingnews.comBiogen downgraded to Hold at Argus on profit decline expectationsApril 4, 2025 | seekingalpha.comBiogen Inc. (NASDAQ:BIIB) Stock Position Lowered by Groupama Asset ManagmentGroupama Asset Managment trimmed its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 51.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,872 shares of the biotechnology company's stock after selling 10,6April 4, 2025 | marketbeat.com Remove Ads Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼1.000.80▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3723▲BIIB Articles Average Week Remove Ads Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today United Therapeutics News Today Incyte News Today BioMarin Pharmaceutical News Today Exelixis News Today Neurocrine Biosciences News Today Exact Sciences News Today Halozyme Therapeutics News Today Repligen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIIB Stock Free BIIB Stock Alerts